Learning Objectives:

  1. Anti-TNF is a primary therapy for inflammatory bowel disease and improves height velocity and outcomes in children with growth failure
  2. Inflammatory bowel disease pathogenesis includes genetics, immunity, environment, and microbiome
  3. Co-occurrence of Vitamin D deficiency is present in 60-92% of children at diagnosis with IBD


Session date: 
06/02/2022 - 12:00pm to 1:00pm CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
D. Brent Polk, MD